News Agency
Men's Weekly

Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

  • Written by PR Newswire
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

MELBOURNE, Australia and SAN FRANCISCO, Oct. 27, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study in the United States.

BioMUSE is a natural history study that aims to track the progression of...

Read more: Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

Driving Business Success with IT Services and IT Procurement

From communication and data storage to cybersecurity and customer engagement, companies depend on technology to operate efficiently and stay competitive. This growing reliance makes professional IT services and strategic IT procurement essential for organisations of all sizes. By leveraging expert support... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion